In human patients with AD, memory deficits come secondary to Aβ deposition9, although important pathological hallmarks such as neuroinflammation and hippocampal sclerosis are present early on during early mild cognitive impairment (EMCI), in addition to tau pathology. This evidence concerns the gene MAPT and Cognitive impairment.